Can we allow a further intake of drugs poorly suspected as responsible in drug reaction with eosinophilia and systemic symptoms? A study of practice.

The occurrence of a new AEs with neurological involvement during the reintroduction of an anti-CD25, in a patient who previously would have had a DRESS, has nothing to do with our study involving DRESS induced by xenobiotics. Finally, any side-effects occurring during slow drug re-introductions in our patients were scrupulously recorded and described, and no patient had neurological involvement. The discussion of a relapse of a DRESS due to an anti-CD25 with neurological involvement without liver or renal involvement is purely hypothetical and has no relation to our study. [Extracted from the article]